Astria Therapeutics (ATXS) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ATXS is expected to report earnings to fall 7.37% to -39 cents per share on November 07

Astria Therapeutics ATXS Stock Earnings Reports

Q3'24

Est.

$-0.40

Q2'24

Missed

by $0.06

Q1'24

Missed

by $0.03

Q4'23

Missed

by $0.08

Q3'23

Missed

by $0.14

The last earnings report on August 12 showed earnings per share of -43 cents, missing the estimate of -37 cents. With 244.36K shares outstanding, the current market capitalization sits at 627.45M.

View a ticker or compare two or three

Compare

ATXS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ATXS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ATXS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

75 State Street

Phone

+1 617 349-1971

Employees

Web

https://www.astriatx.com